since dermal toxicity associated with paa precludes its use in humans and since pfa is already undergoing trials in patients with recurrent herpes labialis , the current results suggest that topical pfa deserved further evaluation in the treatment of mucocutaneous hsv infections , including genital herpes .
C0031681
paa
C0070895
pfa